APOC-III-directed RNA Interaction [EPC]

104 reported adverse events

Drugs of this class: PLOZASIRAN

These side effects are most commonly reported by patients taking drugs of the APOC-III-directed RNA Interaction [EPC] class:

# Side effect Count
0 HEADACHE 21
1 NAUSEA 20
2 BLOOD GLUCOSE INCREASED 15
3 INJECTION SITE PAIN 7
4 FATIGUE 5
5 FEELING ABNORMAL 5
6 HYPERGLYCAEMIA 5
7 BLOOD TRIGLYCERIDES INCREASED 4
8 DIZZINESS 4
9 DRUG INEFFECTIVE 4
See all common reactions for APOC-III-directed RNA Interaction [EPC]

Drugs of the APOC-III-directed RNA Interaction [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ULTRASOUND LIVER ABNORMAL 1 0.0066
1 RENAL ABSCESS 1 0.0012
2 ADMINISTRATION SITE PAIN 1 0.0009
3 PANCREATIC CYST 1 0.0005
4 MOTION SICKNESS 1 0.0005
5 URINARY BLADDER HAEMORRHAGE 1 0.0005
6 TONGUE DISCOMFORT 1 0.0002
7 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
8 CHEILITIS 1 0.0002
9 JAW DISORDER 1 0.0002
See all enriched reactions for APOC-III-directed RNA Interaction [EPC]